henhaobio
Sign in

bioRxivImmunology

Preexisting memory CD4 T cells in nÏave individuals confer robust immunity upon hepatitis B vaccination

G. Elias, P. Meysman, E. Bartholomeus, N. De Neuter, N. Keersmaekers, A. Suls, H. Jansens, A. Souquette, H. De Reu, E. Smits, E. Lion, P. G. Thomas, G. Mortier, P. Van Damme, P. Beutels, K. Laukens, V. Van Tendeloo, B. Ogunjimi

PDFDOIPreprint

Abstract

Antigen recognition through the T cell receptor (TCR) {beta} heterodimer is one of the primary determinants of the adaptive immune response. Vaccines activate naive T cells with high specificity to expand and differentiate into memory T cells. However, antigen-specific memory CD4 T cells exist in unexposed antigen-naive hosts. In this study, we use high-throughput sequencing of memory CD4 TCR{beta} repertoire and machine learning to show that individuals with preexisting vaccine-reactive memory CD4 T cell clonotypes elicited earlier and higher antibody titers and mounted a more robust CD4 T cell response to hepatitis B vaccine. In addition, integration of TCR{beta} sequence patterns into a hepatitis B vaccine specific model can predict which individuals will have an early and more vigorous vaccine-elicited immunity. Thus, the presence of preexisting memory T clonotypes has a significant impact on immunity and can be used to predict immune responses to vaccination.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.